Mawa Patrice Akusa, Webb Emily L, Filali-Mouhim Abdelali, Nkurunungi Gyaviira, Sekaly Rafick-Pierre, Lule Swaib Abubaker, Prentice Sarah, Nash Stephen, Dockrell Hazel M, Elliott Alison M, Cose Stephen
MRC/UVRI Uganda Research Unit on AIDS, P.O. Box 49, Entebbe, Uganda; London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UK.
London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UK.
Vaccine. 2017 Jan 5;35(2):273-282. doi: 10.1016/j.vaccine.2016.11.079. Epub 2016 Nov 30.
Prenatal exposures such as infections and immunisation may influence infant responses. We had an opportunity to undertake an analysis of innate responses in infants within the context of a study investigating the effects of maternal mycobacterial exposures and infection on BCG vaccine-induced responses in Ugandan infants.
Maternal and cord blood samples from 29 mother-infant pairs were stimulated with innate stimuli for 24h and cytokines and chemokines in supernatants were measured using the Luminex® assay. The associations between maternal latent Mycobacterium tuberculosis infection (LTBI), maternal BCG scar (adjusted for each other's effect) and infant responses were examined using linear regression. Principal Component Analysis (PCA) was used to assess patterns of cytokine and chemokine responses. Gene expression profiles for pathways associated with maternal LTBI and with maternal BCG scar were examined using samples collected at one (n=42) and six (n=51) weeks after BCG immunisation using microarray.
Maternal LTBI was positively associated with infant IP-10 responses with an adjusted geometric mean ratio (aGMR) [95% confidence interval (CI)] of 5.10 [1.21, 21.48]. Maternal BCG scar showed strong and consistent associations with IFN-γ (aGMR 2.69 [1.15, 6.17]), IL-12p70 (1.95 [1.10, 3.55]), IL-10 (1.82 [1.07, 3.09]), VEGF (3.55 [1.07, 11.48]) and IP-10 (6.76 [1.17, 38.02]). Further assessment of the associations using PCA showed no differences for maternal LTBI, but maternal BCG scar was associated with higher scores for principal component (PC) 1 (median level of scores: 1.44 in scar-positive versus -0.94 in scar-negative, p=0.020) in the infants. PC1 represented a controlled proinflammatory response. Interferon and inflammation response pathways were up-regulated in infants of mothers with LTBI at six weeks, and in infants of mothers with a BCG scar at one and six weeks after BCG immunisation.
Maternal BCG scar had a stronger association with infant responses than maternal LTBI, with an increased proinflammatory immune profile.
产前暴露如感染和免疫接种可能会影响婴儿的反应。在一项研究中,我们有机会分析婴儿的先天反应,该研究旨在调查乌干达婴儿中母亲接触分枝杆菌和感染对卡介苗诱导反应的影响。
对29对母婴的母血和脐血样本用先天刺激物刺激24小时,使用Luminex®检测法测量上清液中的细胞因子和趋化因子。使用线性回归分析母亲潜伏性结核分枝杆菌感染(LTBI)、母亲卡介苗疤痕(相互调整影响)与婴儿反应之间的关联。主成分分析(PCA)用于评估细胞因子和趋化因子反应模式。使用微阵列分析在卡介苗免疫后1周(n = 42)和6周(n = 51)收集的样本,检测与母亲LTBI和母亲卡介苗疤痕相关途径的基因表达谱。
母亲LTBI与婴儿IP - 10反应呈正相关,调整后的几何平均比(aGMR)[95%置信区间(CI)]为5.10 [1.21, 21.48]。母亲卡介苗疤痕与IFN - γ(aGMR 2.69 [1.15, 6.17])、IL - 12p70(1.95 [1.10, 3.55])、IL - 10(1.82 [1.07, 3.09])、VEGF(3.55 [1.07, 11.48])和IP - 10(6.76 [1.17, 38.02])有强烈且一致的关联。使用PCA对关联进行进一步评估显示,母亲LTBI无差异,但母亲卡介苗疤痕与婴儿主成分(PC)1的较高得分相关(得分中位数:疤痕阳性为1.44,疤痕阴性为 - 0.94,p = 0.020)。PC1代表一种受控的促炎反应。在卡介苗免疫后6周,LTBI母亲的婴儿以及在卡介苗免疫后1周和6周有卡介苗疤痕母亲的婴儿中,干扰素和炎症反应途径上调。
母亲卡介苗疤痕与婴儿反应的关联比母亲LTBI更强,促炎免疫谱增加。